US Commercial Biosimilars Analytics & Provider Contracting

ROLE SUMMARY

The US Commercial organization, which is in the Global Hospital & Biosimilars organization, is comprised of over 200 products, spanning more than 10 therapeutic areas, with annual revenue of over $2.5B.

The Biosimilars Analytics and Provider Contracting role has responsibility for provider contract strategy and analytics for the combined Inflammation & Immunology (I&I) and Oncology biosimilars (BSM) portfolios, with net revenue of ~$0.9B, within the US Commercial organization. This includes eight BSM assets - Abrilada, Inflectra, Nivestym, Nyvepria, Retacrit, Ruxience, Trazimera, Zirabev.

The Biosimilars Analytics and Provider Contracting role will report to the US Commercial Pricing and Commercial Operations Lead.

ROLE RESPONSIBILITIES:

The Biosimilars Provider Contracting role is focused on provider contract strategy and analytics for our Biosimilars portfolio. This role will be responsible for modeling, analytics and foreca...